Home/Filings/4/0001437749-20-014008
4//SEC Filing

Gagnon Suzanne 4

Accession 0001437749-20-014008

CIK 0001029125other

Filed

Jun 25, 8:00 PM ET

Accepted

Jun 26, 4:51 PM ET

Size

5.0 KB

Accession

0001437749-20-014008

Insider Transaction Report

Form 4
Period: 2020-06-24
Gagnon Suzanne
DirectorChief Medical Officer
Transactions
  • Award

    Employee Stock Option (right to buy)

    2020-06-24+40,00040,000 total
    Exercise: $4.98Exp: 2030-06-24Common Stock (40,000 underlying)
Footnotes (1)
  • [F1]Immediately exercisable as to 25% of the shares and scheduled to vest with respect to 25% of the shares on each of June 24, 2021, June 24, 2022 and June 24, 2023.

Issuer

Sun BioPharma, Inc.

CIK 0001029125

Entity typeother

Related Parties

1
  • filerCIK 0001652855

Filing Metadata

Form type
4
Filed
Jun 25, 8:00 PM ET
Accepted
Jun 26, 4:51 PM ET
Size
5.0 KB